Optimind Pharma Statistics
Total Valuation
Optimind Pharma has a market cap or net worth of CAD 515,742. The enterprise value is 530,092.
Important Dates
The next estimated earnings date is Friday, January 29, 2027.
| Earnings Date | Jan 29, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Optimind Pharma has 103.15 million shares outstanding. The number of shares has decreased by -4.25% in one year.
| Current Share Class | 103.15M |
| Shares Outstanding | 103.15M |
| Shares Change (YoY) | -4.25% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.63 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -31.80% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 29.92% |
| Weighted Average Cost of Capital (WACC) | 4.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.72 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.13 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.40 |
| Average Volume (20 Days) | 32,548 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Optimind Pharma had revenue of CAD 91,630 and -136,972 in losses. Loss per share was -0.00.
| Revenue | 91,630 |
| Gross Profit | 54,551 |
| Operating Income | -64,965 |
| Pretax Income | -136,972 |
| Net Income | -136,972 |
| EBITDA | n/a |
| EBIT | -64,965 |
| Loss Per Share | -0.00 |
Full Income Statement Balance Sheet
The company has 37,599 in cash and 71,637 in debt, with a net cash position of -34,038 or -0.00 per share.
| Cash & Cash Equivalents | 37,599 |
| Total Debt | 71,637 |
| Net Cash | -34,038 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -217,131 |
| Book Value Per Share | -0.00 |
| Working Capital | -217,131 |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -30,495 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -49,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 59.53%, with operating and profit margins of -70.90% and -149.48%.
| Gross Margin | 59.53% |
| Operating Margin | -70.90% |
| Pretax Margin | -149.48% |
| Profit Margin | -149.48% |
| EBITDA Margin | n/a |
| EBIT Margin | -70.90% |
| FCF Margin | n/a |
Dividends & Yields
Optimind Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.25% |
| Shareholder Yield | 4.25% |
| Earnings Yield | -26.66% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Optimind Pharma has an Altman Z-Score of -159.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -159.56 |
| Piotroski F-Score | 2 |